RCE 2.33% 44.0¢ recce pharmaceuticals ltd

Recce Pharmaceuticals makes first steps towards new trials

  1. 7,555 Posts.
    lightbulb Created with Sketch. 1042
    • Recce Pharmaceuticals (RCE) has lodged an application to commence human clinical trials for its topical burns treatment, RECCE 327
    • The ASX-lister announced it had registered for the trial with the Australian and New Zealand Clinical Trial Registry for a phase I/II topical burns study
    • The study is set to test 30 patients over two weeks in a bid to test the efficacy of the drug
    • In a broader context, Recce said the application represents one of the final administration stages required before the trial can commence

    Read the full article on the Market Herald here
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
44.0¢
Change
0.010(2.33%)
Mkt cap ! $89.62M
Open High Low Value Volume
43.0¢ 44.0¢ 43.0¢ $24.01K 55.73K

Buyers (Bids)

No. Vol. Price($)
3 72121 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.0¢ 29087 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
44.0¢
  Change
0.010 ( 2.33 %)
Open High Low Volume
43.5¢ 44.0¢ 43.0¢ 7544
Last updated 15.59pm 29/03/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.